A newly finalized guidance document from US FDA emphasizes consensus standards rather than predicate comparisons for establishing substantial equivalence for 510(k) devices.
The new approach, which FDA is calling the "Safety and Performance Based Pathway," effectively expands the abbreviated 510(k) pathway as an alternative